TP53 and neoplasm: Given the relatively low frequency (~30% or less) of sequence mutations of genes other than TP53 both in the current and previous studies, together with prevalence of consistent and frequent SCNA changes across wide range of tumours28, it is likely that the selection processes in the clonal evolution of these tumours is driven by these SCNAs.